TOMMY MCCLUSKEY: Open Payments
NPI 1346711082 · ROGERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 33 payments from 10 companies in 2025. Trend: 2023 $186 · 2024 $304 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $207 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Exact Sciences Corporation | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, FARXIGA, AIRSUPRA, QULIPTA, REXULTI, Cologuard Collection Kit, Auvelity, VIBERZI.
Industry payments across AL — which companies pay providers there.
